title: Comparison of once- and twice-daily naftifine cream regimens with twice-daily clotrimazole in the treatment of tinea pedis.
authors.affiliation: University of Texas Medical Branch, Galveston.
authors.forename: E B
authors.initials: EB
authors.lastname: Smith
authors.forename: K
authors.initials: K
authors.lastname: Wiss
authors.forename: J M
authors.initials: JM
authors.lastname: Hanifin
authors.forename: R E
authors.initials: RE
authors.lastname: Jordon
authors.forename: R P
authors.initials: RP
authors.lastname: Rapini
authors.forename: A E
authors.initials: AE
authors.lastname: Lasser
authors.forename: M B
authors.initials: MB
authors.lastname: Kirschenbaum
authors.forename: L E
authors.initials: LE
authors.lastname: Millikan
authors.forename: L C
authors.initials: LC
authors.lastname: Parish
authors.forename: M J
authors.initials: MJ
authors.lastname: Rapaport
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000499:Allylamine / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives; D000588:Amines / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003022:Clotrimazole / Q000008:administration & dosage* / Q000009:adverse effects; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D014008:Tinea Pedis / Q000188:drug therapy*
chemical_list: D000588:Amines; D000935:Antifungal Agents; D007093:Imidazoles; D000499:Allylamine; C029178:naftifine; D003022:Clotrimazole